Claire BOUTRON, Monique MATHIEU-NOLF, Nicolas PETY, Marc DEVEAUX, « Utilisations détournées du protoxyde d'azote », Annales de Toxicologie Analytique, vol. XII, no 3, (lire en ligne)
Johnson K, Mikhail P, Kim MG, Bosco A et Huynh W, Recreational nitrous oxide-associated neurotoxicity, J. Neurol. Neurosurg. Psychiatry, août 2018, 89(8):897-898, DOI10.1136/jnnp-2017-317768 (résumé)
centres-antipoison.net
Luc de Haro, Jocelyne Arditti et Catherine Messina-Gourlot, Comité de coordination de toxicovigilance, Déviation d’utilisation du protoxyde d’azote (rapport), direction générale de la Santé, , 12 p. (lire en ligne [PDF]).
(en) David R. Lide, CRC Handbook of Chemistry and Physics, Boca Raton, CRC Press/Taylor & Francis, , 89e éd., 2736 p. (ISBN9781420066791, présentation en ligne), p. 9-50.
(en) William M. Haynes, CRC Handbook of Chemistry and Physics, Boca Raton, CRC Press/Taylor & Francis, , 91e éd., 2610 p. (ISBN9781439820773, présentation en ligne), p. 14-40.
(en) David R. Lide, CRC Handbook of Chemistry and Physics, Boca Raton, CRC Press/Taylor & Francis, , 90e éd., 2804 p. (ISBN9781420090840, présentation en ligne).
(en) David R. Lide, CRC Handbook of Chemistry and Physics, Boca Raton, CRC Press, , 83e éd., 2664 p. (ISBN0849304830, présentation en ligne), p. 5-89.
(en) David R. Lide, CRC Handbook of Chemistry and Physics, Boca Raton, CRC Press/Taylor & Francis, , 89e éd., 2736 p. (ISBN9781420066791, présentation en ligne), p. 10-205.
csst.qc.ca
reptox.csst.qc.ca
« Oxyde nitreux » dans la base de données de produits chimiques Reptox de la CSST (organisme québécois responsable de la sécurité et de la santé au travail), consulté le 25 avril 2009.
Entrée « Nitrous oxide » dans la base de données de produits chimiques GESTIS de la IFA (organisme allemand responsable de la sécurité et de la santé au travail) (allemand, anglais) (JavaScript nécessaire).
doi.org
dx.doi.org
(en) David R. Kanter, Claudia Wagner-Riddle, Peter M. Groffman et Eric A. Davidson, « Improving the social cost of nitrous oxide », Nature Climate Change, vol. 11, no 12, , p. 1008–1010 (ISSN1758-678X et 1758-6798, DOI10.1038/s41558-021-01226-z, lire en ligne, consulté le ).
Caroline Victorri-Vigneau (2017), Pharmacologie clinique – Pratiques d’utilisation du MEOPA dans un CHU : quelle conformité ? (MEOPA use practices in a university hospital: Which conformity?), Therapies, vol. 72, no 6, décembre 2017, p. 659-663, DOI10.1016/j.therap.2017.04.003.
(en) Roberto André Grave, Rodrigo da Silveira Nicoloso, Paulo Cezar Cassol, Marcio Luis Busi da Silva, Melissa Paola Mezzari, Celso Aita et Camila Rosan Wuaden, « Determining the effects of tillage and nitrogen sources on soil N2O emission », Soil and Tillage Research, no 175, (DOI10.1016/j.still.2017.08.011, lire en ligne).
(en) R. L. Thompson, L. Lassaletta, P. K. Patra et C. Wilson, « Acceleration of global N 2 O emissions seen from two decades of atmospheric inversion », Nature Climate Change, vol. 9, no 12, , p. 993–998 (ISSN1758-6798, DOI10.1038/s41558-019-0613-7, lire en ligne, consulté le ).
(en) V. N. Parmon, G. I. Panov, A. Uriarte et A. S. Noskov, « Nitrous oxide in oxidation chemistry and catalysis application and production », Elsevier, vol. 100, , p. 115-131 (DOI10.1016/j.cattod.2004.12.012).
Ravishankara A.R., Daniel J.S. et Portmann R.W. (2009), Nitrous Oxide (N2O): The Dominant Ozone-Depleting Substance Emitted in the 21st Century, Science, 326 (5949): 123–5, Bibcode : 2009Sci…326..123R, DOI10.1126/science.1176985, PMID19713491.
Yamakura T. et Harris R.A., « Effects of gaseous anaesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol », Anesthesiology, vol. 93, no 4, , p. 1095–101 (PMID11020766, DOI10.1097/00000542-200010000-00034).
Mennerick S., Jevtovic-Todorovic V., Todorovic S.M., Shen W., Olney J.W. et Zorumski C.F., « Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures », Journal of Neuroscience, vol. 18, no 23, , p. 9716–26 (PMID9822732, DOI10.1523/JNEUROSCI.18-23-09716.1998).
Gruss M., Bushell T.J., Bright D.P., Lieb W.R., Mathie A. et Franks N.P., « Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane », Molecular Pharmacology, vol. 65, no 2, , p. 443–52 (PMID14742687, DOI10.1124/mol.65.2.443).
Roland M. Atkinson, J. DeWayne Green, Dennis E. Chenoweth et Judith Holmes Atkinson, « Subjective Effects of Nitrous Oxide: Cognitive, Emotional, Perceptual and Transcendental Experiences », Journal of Psychedelic Drugs, vol. 11, no 4, , p. 317–330 (DOI10.1080/02791072.1979.10471415).
Diana J. Walker et James P. Zacny, « Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers », Drug and Alcohol Dependence, vol. 64, no 1, , p. 85–96 (PMID11470344, DOI10.1016/s0376-8716(00)00234-9).
Jay M., « Nitrous oxide: recreational use, regulation and harm reduction », Drugs and Alcohol Today, vol. 8, no 3, , p. 22–25 (DOI10.1108/17459265200800022).
S. Sakamoto, S. Nakao, M. Masuzawa, Takefumi Inada, Mervyn Maze, Nicholas P. Franks et Koh Shingu, « The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study », Anesthesia and Analgesia, vol. 103, no 6, , p. 1459–63 (PMID17122223, DOI10.1213/01.ane.0000247792.03959.f1, CiteSeerx10.1.1.317.6613).
Benturquia N., Le Marec T., Scherrmann J.M. et Noble F., « Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward », Neuroscience, vol. 155, no 2, , p. 341–4 (PMID18571333, DOI10.1016/j.neuroscience.2008.05.015).
Lichtigfeld F.J. et Gillman M.A., « Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal », Clinical Neuropharmacology, vol. 19, no 3, , p. 246–51 (PMID8726543, DOI10.1097/00002826-199619030-00006).
Koyanagi S., Himukashi S., Mukaida K., Shichino T. et Fukuda K., « Dopamine D2-like receptor in the nucleus accumbens is involved in the antinociceptive effect of nitrous oxide », Anesthesia and Analgesia, vol. 106, no 6, , p. 1904–9 (PMID18499630, DOI10.1213/ane.0b013e318172b15b, CiteSeerx10.1.1.327.9838).
David H.N., Ansseau M., Lemaire M. et Abraini J.H., « Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization », Biological Psychiatry, vol. 60, no 1, , p. 49–57 (PMID16427030, DOI10.1016/j.biopsych.2005.10.007).
N. Benturquia, S. Le Guen, C. Canestrelli, V. Lagente, G. Apiou, B.P. Roques et F. Noble, « Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice », Neuroscience, vol. 149, no 3, , p. 477–86 (PMID17905521, DOI10.1016/j.neuroscience.2007.08.003, lire en ligne).
Ramsay D.S., Watson C.H., Leroux B.G., Prall C.W. et Kaiyala K.J., « Conditioned place aversion and self-administration of nitrous oxide in rats », Pharmacology Biochemistry and Behavior, vol. 74, no 3, , p. 623–33 (PMID12543228, DOI10.1016/S0091-3057(02)01048-1).
Zacny J.P. et Galinkin J.L., « Psychotropic drugs used in anesthesia practice: abuse liability and epidemiology of abuse », Anesthesiology, vol. 90, no 1, , p. 269–88 (PMID9915336, DOI10.1097/00000542-199901000-00033).
Dohrn C.S., Lichtor J.L., Coalson D.W., Uitvlugt A., de Wit H. et Zacny J.P., « Reinforcing effects of extended inhalation of nitrous oxide in humans », Drug and Alcohol Dependence, vol. 31, no 3, , p. 265–80 (PMID8462415, DOI10.1016/0376-8716(93)90009-F).
Walker D.J. et Zacny J.P., « Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers », Drug and Alcohol Dependence, vol. 64, no 1, , p. 85–96 (PMID11470344, DOI10.1016/S0376-8716(00)00234-9).
Emmanouil DE, Johnson CH, Quock RM, « Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors », Psychopharmacology, vol. 115, nos 1–2, , p. 167–72 (PMID7862891, DOI10.1007/BF02244768).
Zacny JP, Yajnik S, Coalson D, Lichtor JL, Apfelbaum JL, Rupani G, Young C, Thapar P, Klafta J, « Flumazenil may attenuate some subjective effects of nitrous oxide in humans: a preliminary report », Pharmacology Biochemistry and Behavior, vol. 51, no 4, , p. 815–9 (PMID7675863, DOI10.1016/0091-3057(95)00039-Y).
Berkowitz BA, Finck AD, Hynes MD, Ngai SH, « Tolerance to nitrous oxide analgesia in rats and mice », Anesthesiology, vol. 51, no 4, , p. 309–12 (PMID484891, DOI10.1097/00000542-197910000-00006).
Branda EM, Ramza JT, Cahill FJ, Tseng LF, Quock RM, « Role of brain dynorphin in nitrous oxide antinociception in mice », Pharmacology Biochemistry and Behavior, vol. 65, no 2, , p. 217–21 (PMID10672972, DOI10.1016/S0091-3057(99)00202-6).
Guo TZ, Davies MF, Kingery WS, Patterson AJ, Limbird LE, Maze M, « Nitrous oxide produces antinociceptive response via alpha2B and/or alpha2C adrenoceptor subtypes in mice », Anesthesiology, vol. 90, no 2, , p. 470–6 (PMID9952154, DOI10.1097/00000542-199902000-00022).
Sawamura S, Kingery WS, Davies MF, Agashe GS, Clark JD, Koblika BK, Hashimoto T et Maze M, « Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors », J. Neurosci., vol. 20, no 24, , p. 9242–51 (PMID11125002, DOI10.1523/JNEUROSCI.20-24-09242.2000).
Maze M. et Fujinaga M., « Recent advances in understanding the actions and toxicity of nitrous oxide », Anaesthesia, vol. 55, no 4, , p. 311–4 (PMID10781114, DOI10.1046/j.1365-2044.2000.01463.x).
Jordan J.T., Weiser J. et Van Ness P.C., Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration, Neurol. Clin. Pract., août 2014, 4(4):358-361, DOI10.1212/CPJ.000000000000001.
Chaugny C., Simon J., Collin-Masson H., De Beauchêne M., Cabral D., Fagniez O. et Veyssier-Belot C., Carence en vitamine B12 par toxicité du protoxyde d’azote : une cause méconnue de sclérose combinée de la moelle, Rev. Med. Interne, mai 2014, 35(5):328-32, DOI10.1016/j.revmed.2013.04.018.
Egan W, Steinberg E et Rose J, Vitamin B12 deficiency-induced neuropathy secondary to prolonged recreational use of nitrous oxide, Am. J. Emerg. Med., septembre 2018, 36(9):1717.e1-1717.e2, DOI10.1016/j.ajem.2018.05.029 (résumé)
Antonucci MU, Subacute Combined Degeneration from Recreational Nitrous Oxide Inhalation, J. Emerg. Med., mai 2018, 54(5):e105-e107, DOI10.1016/j.jemermed.2018.01.045.
Buizert A, Sharma R et Koppen H, When the Laughing Stops: Subacute Combined Spinal Cord Degeneration Caused by Laughing Gas Use, J. Addict. Med., mai-juin 2017, 11(3):235-236, DOI10.1097/ADM.0000000000000295 (résumé)
Johnson K, Mikhail P, Kim MG, Bosco A et Huynh W, Recreational nitrous oxide-associated neurotoxicity, J. Neurol. Neurosurg. Psychiatry, août 2018, 89(8):897-898, DOI10.1136/jnnp-2017-317768 (résumé)
Morris N, Lynch K et Greenberg SA (2015), Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency, Muscle Nerve, avril, 51(4):614-6, DOI10.1002/mus.24482.
elsevier.com
linkinghub.elsevier.com
(en) Roberto André Grave, Rodrigo da Silveira Nicoloso, Paulo Cezar Cassol, Marcio Luis Busi da Silva, Melissa Paola Mezzari, Celso Aita et Camila Rosan Wuaden, « Determining the effects of tillage and nitrogen sources on soil N2O emission », Soil and Tillage Research, no 175, (DOI10.1016/j.still.2017.08.011, lire en ligne).
Cécile Bidault, « « Gaz hilarant » : les cas graves liés à la consommation de protoxyde d'azote se multiplient dans le Nord », France Bleu Nord, (lire en ligne).
N. Benturquia, S. Le Guen, C. Canestrelli, V. Lagente, G. Apiou, B.P. Roques et F. Noble, « Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice », Neuroscience, vol. 149, no 3, , p. 477–86 (PMID17905521, DOI10.1016/j.neuroscience.2007.08.003, lire en ligne).
(en) David R. Kanter, Claudia Wagner-Riddle, Peter M. Groffman et Eric A. Davidson, « Improving the social cost of nitrous oxide », Nature Climate Change, vol. 11, no 12, , p. 1008–1010 (ISSN1758-678X et 1758-6798, DOI10.1038/s41558-021-01226-z, lire en ligne, consulté le ).
(en) R. L. Thompson, L. Lassaletta, P. K. Patra et C. Wilson, « Acceleration of global N 2 O emissions seen from two decades of atmospheric inversion », Nature Climate Change, vol. 9, no 12, , p. 993–998 (ISSN1758-6798, DOI10.1038/s41558-019-0613-7, lire en ligne, consulté le ).
Elsa Mari, « Alerte au protoxyde d’azote, drogue du fou rire », Le Parisien, (lire en ligne).
lexpress.fr
« Drogue : le gaz hilarant fait des ravages », L'Express, (lire en ligne).
liberation.fr
Sarah Finger, « Montpellier : le succès stupéfiant du gaz hilarant », Libération, (lire en ligne).
lww.com
journals.lww.com
Buizert A, Sharma R et Koppen H, When the Laughing Stops: Subacute Combined Spinal Cord Degeneration Caused by Laughing Gas Use, J. Addict. Med., mai-juin 2017, 11(3):235-236, DOI10.1097/ADM.0000000000000295 (résumé)
mdconsult.com
(en) Michael A. Miller, Vicky Martinez, Richard McCarthy et Manish M. Patel, « Nitrous oxide whippit abuse presenting as clinical B12 deficiency and ataxia », American Journal of Emergency Medicine, vol. 22, no 2, mars 2004 (lire en ligne).
(en) David R. Kanter, Claudia Wagner-Riddle, Peter M. Groffman et Eric A. Davidson, « Improving the social cost of nitrous oxide », Nature Climate Change, vol. 11, no 12, , p. 1008–1010 (ISSN1758-678X et 1758-6798, DOI10.1038/s41558-021-01226-z, lire en ligne, consulté le ).
(en) R. L. Thompson, L. Lassaletta, P. K. Patra et C. Wilson, « Acceleration of global N 2 O emissions seen from two decades of atmospheric inversion », Nature Climate Change, vol. 9, no 12, , p. 993–998 (ISSN1758-6798, DOI10.1038/s41558-019-0613-7, lire en ligne, consulté le ).
nih.gov
ncbi.nlm.nih.gov
Ravishankara A.R., Daniel J.S. et Portmann R.W. (2009), Nitrous Oxide (N2O): The Dominant Ozone-Depleting Substance Emitted in the 21st Century, Science, 326 (5949): 123–5, Bibcode : 2009Sci…326..123R, DOI10.1126/science.1176985, PMID19713491.
Yamakura T. et Harris R.A., « Effects of gaseous anaesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol », Anesthesiology, vol. 93, no 4, , p. 1095–101 (PMID11020766, DOI10.1097/00000542-200010000-00034).
Mennerick S., Jevtovic-Todorovic V., Todorovic S.M., Shen W., Olney J.W. et Zorumski C.F., « Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures », Journal of Neuroscience, vol. 18, no 23, , p. 9716–26 (PMID9822732, DOI10.1523/JNEUROSCI.18-23-09716.1998).
Gruss M., Bushell T.J., Bright D.P., Lieb W.R., Mathie A. et Franks N.P., « Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane », Molecular Pharmacology, vol. 65, no 2, , p. 443–52 (PMID14742687, DOI10.1124/mol.65.2.443).
Diana J. Walker et James P. Zacny, « Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers », Drug and Alcohol Dependence, vol. 64, no 1, , p. 85–96 (PMID11470344, DOI10.1016/s0376-8716(00)00234-9).
S. Sakamoto, S. Nakao, M. Masuzawa, Takefumi Inada, Mervyn Maze, Nicholas P. Franks et Koh Shingu, « The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study », Anesthesia and Analgesia, vol. 103, no 6, , p. 1459–63 (PMID17122223, DOI10.1213/01.ane.0000247792.03959.f1, CiteSeerx10.1.1.317.6613).
Benturquia N., Le Marec T., Scherrmann J.M. et Noble F., « Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward », Neuroscience, vol. 155, no 2, , p. 341–4 (PMID18571333, DOI10.1016/j.neuroscience.2008.05.015).
Lichtigfeld F.J. et Gillman M.A., « Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal », Clinical Neuropharmacology, vol. 19, no 3, , p. 246–51 (PMID8726543, DOI10.1097/00002826-199619030-00006).
Koyanagi S., Himukashi S., Mukaida K., Shichino T. et Fukuda K., « Dopamine D2-like receptor in the nucleus accumbens is involved in the antinociceptive effect of nitrous oxide », Anesthesia and Analgesia, vol. 106, no 6, , p. 1904–9 (PMID18499630, DOI10.1213/ane.0b013e318172b15b, CiteSeerx10.1.1.327.9838).
David H.N., Ansseau M., Lemaire M. et Abraini J.H., « Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization », Biological Psychiatry, vol. 60, no 1, , p. 49–57 (PMID16427030, DOI10.1016/j.biopsych.2005.10.007).
N. Benturquia, S. Le Guen, C. Canestrelli, V. Lagente, G. Apiou, B.P. Roques et F. Noble, « Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice », Neuroscience, vol. 149, no 3, , p. 477–86 (PMID17905521, DOI10.1016/j.neuroscience.2007.08.003, lire en ligne).
Ramsay D.S., Watson C.H., Leroux B.G., Prall C.W. et Kaiyala K.J., « Conditioned place aversion and self-administration of nitrous oxide in rats », Pharmacology Biochemistry and Behavior, vol. 74, no 3, , p. 623–33 (PMID12543228, DOI10.1016/S0091-3057(02)01048-1).
Wood R.W., Grubman J. et Weiss B., « Nitrous oxide self-administration by the squirrel monkey », The Journal of Pharmacology and Experimental Therapeutics, vol. 202, no 3, , p. 491–9 (PMID408480).
Zacny J.P. et Galinkin J.L., « Psychotropic drugs used in anesthesia practice: abuse liability and epidemiology of abuse », Anesthesiology, vol. 90, no 1, , p. 269–88 (PMID9915336, DOI10.1097/00000542-199901000-00033).
Dohrn C.S., Lichtor J.L., Coalson D.W., Uitvlugt A., de Wit H. et Zacny J.P., « Reinforcing effects of extended inhalation of nitrous oxide in humans », Drug and Alcohol Dependence, vol. 31, no 3, , p. 265–80 (PMID8462415, DOI10.1016/0376-8716(93)90009-F).
Walker D.J. et Zacny J.P., « Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers », Drug and Alcohol Dependence, vol. 64, no 1, , p. 85–96 (PMID11470344, DOI10.1016/S0376-8716(00)00234-9).
Emmanouil DE, Johnson CH, Quock RM, « Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors », Psychopharmacology, vol. 115, nos 1–2, , p. 167–72 (PMID7862891, DOI10.1007/BF02244768).
Zacny JP, Yajnik S, Coalson D, Lichtor JL, Apfelbaum JL, Rupani G, Young C, Thapar P, Klafta J, « Flumazenil may attenuate some subjective effects of nitrous oxide in humans: a preliminary report », Pharmacology Biochemistry and Behavior, vol. 51, no 4, , p. 815–9 (PMID7675863, DOI10.1016/0091-3057(95)00039-Y).
Berkowitz BA, Finck AD, Hynes MD, Ngai SH, « Tolerance to nitrous oxide analgesia in rats and mice », Anesthesiology, vol. 51, no 4, , p. 309–12 (PMID484891, DOI10.1097/00000542-197910000-00006).
Branda EM, Ramza JT, Cahill FJ, Tseng LF, Quock RM, « Role of brain dynorphin in nitrous oxide antinociception in mice », Pharmacology Biochemistry and Behavior, vol. 65, no 2, , p. 217–21 (PMID10672972, DOI10.1016/S0091-3057(99)00202-6).
Guo TZ, Davies MF, Kingery WS, Patterson AJ, Limbird LE, Maze M, « Nitrous oxide produces antinociceptive response via alpha2B and/or alpha2C adrenoceptor subtypes in mice », Anesthesiology, vol. 90, no 2, , p. 470–6 (PMID9952154, DOI10.1097/00000542-199902000-00022).
Sawamura S, Kingery WS, Davies MF, Agashe GS, Clark JD, Koblika BK, Hashimoto T et Maze M, « Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors », J. Neurosci., vol. 20, no 24, , p. 9242–51 (PMID11125002, DOI10.1523/JNEUROSCI.20-24-09242.2000).
Maze M. et Fujinaga M., « Recent advances in understanding the actions and toxicity of nitrous oxide », Anaesthesia, vol. 55, no 4, , p. 311–4 (PMID10781114, DOI10.1046/j.1365-2044.2000.01463.x).
ofdt.fr
Clément Gérome, Agnès Cadet-Taïrou, Michel Gandilhon, Maitena Milhet, Magali Martinez et Thomas Néfau, « Substances psychoactives, usagers et marchés : les tendances récentes (2017-2018) », Tendances, OFDT, Observatoire français des drogues et des toxicomanies, no 129, (lire en ligne).
ouest-france.fr
« « Gaz hilarant » : les sénateurs votent l’interdiction de la vente aux mineurs », Ouest France, (lire en ligne).
S. Sakamoto, S. Nakao, M. Masuzawa, Takefumi Inada, Mervyn Maze, Nicholas P. Franks et Koh Shingu, « The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study », Anesthesia and Analgesia, vol. 103, no 6, , p. 1459–63 (PMID17122223, DOI10.1213/01.ane.0000247792.03959.f1, CiteSeerx10.1.1.317.6613).
Koyanagi S., Himukashi S., Mukaida K., Shichino T. et Fukuda K., « Dopamine D2-like receptor in the nucleus accumbens is involved in the antinociceptive effect of nitrous oxide », Anesthesia and Analgesia, vol. 106, no 6, , p. 1904–9 (PMID18499630, DOI10.1213/ane.0b013e318172b15b, CiteSeerx10.1.1.327.9838).
Egan W, Steinberg E et Rose J, Vitamin B12 deficiency-induced neuropathy secondary to prolonged recreational use of nitrous oxide, Am. J. Emerg. Med., septembre 2018, 36(9):1717.e1-1717.e2, DOI10.1016/j.ajem.2018.05.029 (résumé)